US equities |
MU $1,029.00 ▼-0.66% NVDA $229.28 ▼-0.52% SPCX $162.57 ▲+1.25% TSLA $382.70 ▲+2.05% AAPL $336.64 ▼-1.11% MSFT $535.07 ▲+2.38% AMZN $262.43 ▲+3.29% META $718.67 ▼-0.31%
FinancialContent

AtriCure, Inc. - Common Stock (NQ:ATRC)

55.81 +2.97 (+5.62%)
Delayed Quote Updated: 4:00 PM EDT, Oct 9, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about AtriCure, Inc. - Common Stock

< Previous 1 2 3 4 Next >
News headline image
AtriCure to Participate in the 2026 Wells Fargo Health Care Conference
From AtriCure, Inc.
Via Business Wire
News headline image
AtriCure to Participate at Upcoming Investor Conferences
From AtriCure, Inc.
Via Business Wire
News headline image
AtriCure Reports Second Quarter 2026 Financial Results
From AtriCure, Inc.
Via Business Wire
News headline image
AtriCure to Announce Second Quarter 2026 Financial Results
From AtriCure, Inc.
Via Business Wire
News headline image
AtriCure to Participate in the Goldman Sachs 47th Annual Global Health Care Conference
From AtriCure, Inc.
Via Business Wire
News headline image
AtriCure Reports First Quarter 2026 Financial Results
From AtriCure, Inc.
Via Business Wire
News headline image
AtriCure to Participate in the 2026 Bank of America Securities Health Care Conference
From AtriCure, Inc.
Via Business Wire
News headline image
AtriCure to Announce First Quarter 2026 Financial Results
From AtriCure, Inc.
Via Business Wire
News headline image
AtriCure to Participate in the Citizens Life Sciences Conference
From AtriCure, Inc.
Via Business Wire
News headline image
AtriCure Reports Fourth Quarter 2025 and Full Year 2025 Financial Results
From AtriCure, Inc.
Via Business Wire
News headline image
AtriCure to Announce Fourth Quarter and Full Year 2025 Financial Results
From AtriCure, Inc.
Via Business Wire
News headline image
AtriCure Reports Preliminary Results for Fourth Quarter and Full Year 2025, Provides Financial Outlook for 2026
From AtriCure, Inc.
Via Business Wire
News headline image
AI Diagnostics: The End of the High-Cost Imaging Era
Issued on behalf of VentriPoint Diagnostics Ltd. 
From Equity Insider
Via GlobeNewswire
News headline image
AtriCure to Participate in the J.P. Morgan 44th Annual Healthcare Conference
From AtriCure, Inc.
Via Business Wire
News headline image
AtriCure Announces the First Patients Treated with Novel Dual Energy Platform
From AtriCure, Inc.
Via Business Wire
News headline image
AtriCure to Participate in the Piper Sandler 37th Annual Healthcare Conference
From AtriCure, Inc.
Via Business Wire
News headline image
AtriCure Reports Third Quarter 2025 Financial Results; Raises Financial Outlook for 2025
From AtriCure, Inc.
Via Business Wire
News headline image
AtriCure Announces the First Patient Treated in the BoxX-NoAF Clinical Trial
From AtriCure, Inc.
Via Business Wire
News headline image
AtriCure to Participate in Upcoming Investor Conferences
From AtriCure, Inc.
Via Business Wire
News headline image
AtriCure to Announce Third Quarter 2025 Financial Results
From AtriCure, Inc.
Via Business Wire
News headline image
AtriCure Announces the Launch of the cryoXT™ Device for Post-Operative Pain Management Following Amputation
From AtriCure, Inc.
Via Business Wire
News headline image
AtriCure to Participate in the 2025 Wells Fargo Healthcare Conference
From AtriCure, Inc.
Via Business Wire
News headline image
AtriCure Reports Second Quarter 2025 Financial Results; Raises Financial Outlook for 2025
From AtriCure, Inc.
Via Business Wire
News headline image
AtriCure to Participate in the Canaccord Genuity 45th Annual Growth Conference
From AtriCure, Inc.
Via Business Wire
News headline image
AtriCure Completes Enrollment in LeAAPS Clinical Trial for Stroke Prevention
From AtriCure, Inc.
Via Business Wire
News headline image
AtriCure to Announce Second Quarter 2025 Financial Results
From AtriCure, Inc.
Via Business Wire
News headline image
AtriCure to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference
From AtriCure, Inc.
Via Business Wire
News headline image
AtriCure Reports First Quarter 2025 Financial Results
From AtriCure, Inc.
Via Business Wire
News headline image
AtriCure Announces First Use of the AtriClip PRO-Mini® Device
From AtriCure, Inc.
Via Business Wire
News headline image
AtriCure to Announce First Quarter 2025 Financial Results
From AtriCure, Inc.
Via Business Wire
< Previous 1 2 3 4 Next >